Skip to main content
Premium Trial:

Request an Annual Quote

Arrayit Licenses Microarrays, Reagents to Belmedtechnika

NEW YORK (GenomeWeb News) — Arrayit has licensed its microarray platform and associated reagents to Belmedtechnika, an equipment provider in Belarus, Arrayit said yesterday.

Arrayit, a subsidiary of Integrated Media Holdings, said that Belmedtechnika will deploy its high-throughput genotyping platform to screen and test number patient samples "quickly, affordably, and accurately."

The licensing agreement permits Belmedtechnika to use Arrayit's multi-patient platform to examine many patients' DNA samples at one time. Belmedtechnika also gained the right to use Arrayit's contact printing technology for diagnostic applications.

Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.